Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

被引:84
作者
Shen, Feng [1 ]
Zheng, Rui-Dan [2 ]
Mi, Yu-Qiang [3 ]
Wang, Xiao-Ying [4 ]
Pan, Qin [1 ]
Chen, Guang-Yu [1 ]
Cao, Hai-Xia [1 ]
Chen, Ming-Li [5 ]
Xu, Liang [3 ]
Chen, Jian-Neng [2 ]
Cao, Yi [1 ]
Zhang, Rui-Nan [1 ]
Xu, Lei-Ming [1 ]
Fan, Jian-Gao [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Gastroenterol, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China
[2] Xiamen Univ, Affiliated Dongnan Hosp, Res & Therapy Ctr Liver Dis, Zhangzhou 363000, Fujian Province, Peoples R China
[3] Tianjin Hosp Infect Dis, Tianjin Res Inst Liver Dis, Tianjin 300192, Peoples R China
[4] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Pathol, Sch Med, Shanghai 200092, Peoples R China
[5] Shanghai Jiao Tong Univ, Dept UItrasound, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China
关键词
Fatty liver; Nonalcoholic; Controlled attenuation parameter; Transient elastography; Chronic hepatitis B; FATTY LIVER-DISEASE; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; FIBROSIS; CAP; CHALLENGES; VALIDATION; DIAGNOSIS; TOOL;
D O I
10.3748/wjg.v20.i16.4702
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the performance of a novel non-inva-sive controlled attenuation parameter (CAP) to assess liver steatosis. METHODS: This was a multi-center prospective cohort study. Consecutive patients (aged >= 18 years) who had undergone percutaneous liver biopsy and CAP measurement were recruited from three Chinese liver centers. Steatosis was categorized as S0: < 5%; S1: 5%-33%; S2: 34%-66%; or S3: >= 67%, according to the nonalcoholic fatty liver disease (NAFLD) activity score. The FibroScan((R)) 502 equipped with the M probe (Echosens, Paris, France) was used to capture both CAP and liver stiffness measurement values simultaneously. Receiver operating characteristic curves were plotted, and the areas under the curves were calculated to determine the diagnostic efficacy. The accuracy of the CAP values at the optimal thresholds was defined by maximizing the sum of sensitivity and specificity (maximum Youden index). RESULTS: A total of 152 patients were recruited, including 52 (34.2%) patients with NAFLD and 100 (65.8%) with chronic hepatitis B (CHB) virus infection. After adjustment, the steatosis grade (OR = 37.12; 95% CI: 21.63-52.60, P < 0.001) and body mass index (BMI, OR = 6.20; 95% CI: 2.92-9.48, P < 0.001) were found independently associated with CAP by multivariate linear regression analysis. CAP was not influenced by inflammation, fibrosis or aetiology. The median CAP values and interquartile ranges among patients with S0, S1, S2 and S3 steatosis were 211 (181-240) dB/m, 270 (253-305) dB/m, 330 (302-360) dB/m, and 346 (313-363) dB/m, respectively. The cut-offs for the CAP values in all patients with steatosis >= 5%, >= 34% and >= 67% were 253 dB/m, 285 dB/m and 310 dB/m, respectively. The areas under the curves were 0.92, 0.92 and 0.88 for steatosis >= 5%, >= 34% and >= 67%, respectively. No significant differences were found in the CAP values between the NAFLD group and the CHB group in each steatosis grade.
引用
收藏
页码:4702 / 4711
页数:10
相关论文
共 34 条
[1]   Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions [J].
Ahn, Sang Hoon ;
Chan, Henry L. Y. ;
Chen, Pei-Jer ;
Cheng, Jun ;
Goenka, Mahesh K. ;
Hou, Jinlin ;
Lim, Seng Gee ;
Omata, Masao ;
Piratvisuth, Teerha ;
Xie, Qing ;
Yim, Hyung Joon ;
Yuen, Man-Fung .
HEPATOLOGY INTERNATIONAL, 2010, 4 (01) :386-395
[2]  
Audière S, 2010, LECT NOTES COMPUT SC, V6362, P34
[3]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[4]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[5]   Prevalence of and risk factors for hepatic steatosis in northern Italy [J].
Bellentani, S ;
Saccoccio, G ;
Masutti, F ;
Crocè, LS ;
Brandi, G ;
Sasso, F ;
Cristanini, G ;
Tiribelli, C .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117
[6]   The burden of liver disease in Europe: A review of available epidemiological data [J].
Blachier, Martin ;
Leleu, Henri ;
Peck-Radosavljevic, Markus ;
Valla, Dominique-Charles ;
Roudot-Thoraval, Francoise .
JOURNAL OF HEPATOLOGY, 2013, 58 (03) :593-608
[7]   Iron and steatohepatitis [J].
Corradini, Elena ;
Pietrangelo, Antonello .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 :42-46
[8]   Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography [J].
de Ledinghen, Victor ;
Vergniol, Julien ;
Foucher, Juliette ;
Merrouche, Wassil ;
le Bail, Brigitte .
LIVER INTERNATIONAL, 2012, 32 (06) :911-918
[9]   Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010 [J].
Fan, Jian Gao ;
Jia, Ji Dong ;
Li, You Ming ;
Wang, Bing Yuan ;
Lu, Lun Gen ;
Shi, Jun Pin ;
Chan, Lik Yuen .
JOURNAL OF DIGESTIVE DISEASES, 2011, 12 (01) :38-44
[10]   Epidemiology of non-alcoholic fatty liver disease in China [J].
Fan, Jian-Gao ;
Farrell, Geoffrey C. .
JOURNAL OF HEPATOLOGY, 2009, 50 (01) :204-210